AMINOSYN II 10% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aminosyn Ii 10% In Plastic Container, and when can generic versions of Aminosyn Ii 10% In Plastic Container launch?
Aminosyn Ii 10% In Plastic Container is a drug marketed by Icu Medical Inc and is included in one NDA.
The generic ingredient in AMINOSYN II 10% IN PLASTIC CONTAINER is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aminosyn Ii 10% In Plastic Container
A generic version of AMINOSYN II 10% IN PLASTIC CONTAINER was approved as amino acids by B BRAUN on April 13th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMINOSYN II 10% IN PLASTIC CONTAINER?
- What are the global sales for AMINOSYN II 10% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for AMINOSYN II 10% IN PLASTIC CONTAINER?
Summary for AMINOSYN II 10% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
DailyMed Link: | AMINOSYN II 10% IN PLASTIC CONTAINER at DailyMed |
Pharmacology for AMINOSYN II 10% IN PLASTIC CONTAINER
Drug Class | Amino Acid |
US Patents and Regulatory Information for AMINOSYN II 10% IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Icu Medical Inc | AMINOSYN II 10% IN PLASTIC CONTAINER | amino acids | INJECTABLE;INJECTION | 020015-001 | Dec 19, 1991 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |